Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Cipla Ltd ( (IN:CIPLA) ) has provided an update.
Cipla Limited has announced that shareholders have approved, via postal ballot, key board and management changes, including the appointment of Achin Gupta as director, managing director and global chief executive officer, and the re-appointment of Prathivadibhayankara Rajagopalan Ramesh as independent director. The resolutions, passed with the requisite majority, formalise a leadership transition at the top of the organisation and reinforce Cipla’s governance framework, with detailed voting results and the scrutiniser’s report made available on the company and e-voting agency websites.
More about Cipla Ltd
Cipla Limited is a Mumbai-headquartered pharmaceutical company engaged in manufacturing and marketing a wide range of generic and branded medicines. The company operates globally with a focus on formulations and active pharmaceutical ingredients, serving regulated and emerging markets across multiple therapeutic segments.
Average Trading Volume: 113,333
Technical Sentiment Signal: Hold
Current Market Cap: 1004.8B INR
For detailed information about CIPLA stock, go to TipRanks’ Stock Analysis page.